Ra­dio­phar­ma­ceu­ti­cal biotech Ra­dio­net­ics in fundrais­ing mode with $54.2M so far

Ra­dio­net­ics On­col­o­gy is in the midst of a fundrais­ing dri­ve worth $68.7 mil­lion, with the Cal­i­for­nia-based com­pa­ny hav­ing raised $54.2 mil­lion so far, per an SEC fil­ing on Mon­day.

The fil­ing it­self did not dis­close who has in­vest­ed in the round so far, or what the mon­ey is ear­marked for. In Feb­ru­ary, the com­pa­ny not­ed it plans to file three INDs in 2023 and 2024. Ra­dio­net­ics did not im­me­di­ate­ly re­spond to End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER